Hysteroscopic Resection Of Cesarean Uterine Scar Defect Versus Levonorgestrel-releasing Intrauterine Device In Management of Patients With Postmenstrual Spotting :A Comparative study

Not Applicable

Not yet recruiting

• Conditions: postmenstrual bleeding

• Registration Number: PACTR202209817035302
• Lead Sponsor: suez canal university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-22
• Last Update Posted: 2023-05-29

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 48

Inclusion Criteria

Patients aged between 20 and 45 years
- Women with a previous caesarean section (at least one previous cesarean delivery)
- postmenstrual spotting of at least two days and in whom ultrasound had shown a niche, they are considered to undergo a hysteroscopic niche resection or to receive
LNG-IUD (52 mg) insertion.

Exclusion Criteria

-Fertility wish within 1 year
-Irregular menstrual cycle before the last cesarean delivery,
-Presence of an intrauterine device
-Coagulopathy
-The length of the uterine cavity less than 6 cm or more than 10 cm
-Current exogenous hormone treatment
-Other gynecological conditions that could cause prolonged bleeding such as leiomyoma, endometrial hyperplasia, ovarian endometriosis and pregnancy

-Patients had received hysteroscopic resection or LNG-IUD before intervention

-In hysteroscopy group, additional exclusion criteria are contraindication for general anesthesia and with residual myometrium thickness (RMT) less than 2.2 mm to prevent bladder injury and uterine perforation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified